WallStreetZenWallStreetZen

NASDAQ: DYNT
Dynatronics Corp Stock

$0.41+0.02 (+5.13%)
Updated May 24, 2024
DYNT Price
$0.41
Fair Value Price
N/A
Market Cap
$2.18M
52 Week Low
$0.37
52 Week High
$0.91
P/E
-0.34x
P/B
0.15x
P/S
0.07x
PEG
N/A
Dividend Yield
N/A
Revenue
$33.60M
Earnings
-$4.39M
Gross Margin
21.4%
Operating Margin
-12.12%
Profit Margin
-15.3%
Debt to Equity
0.87
Operating Cash Flow
-$2M
Beta
0.16
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

DYNT Overview

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. Its orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company provides therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. It also offers power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, and other related equipment. In addition, the company provides clinical supplies, including exercise bands and tubings, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals, as well as online. It also exports its products to approximately 30 countries. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DYNT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

DYNT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DYNT is good value based on its book value relative to its share price (0.15x), compared to the US Medical Devices industry average (3.95x)
P/B vs Industry Valuation
DYNT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more DYNT due diligence checks available for Premium users.

Be the first to know about important DYNT news, forecast changes, insider trades & much more!

DYNT News

Valuation

DYNT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.34x
Industry
30.23x
Market
32.03x

DYNT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.15x
Industry
3.95x
DYNT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

DYNT's financial health

Profit margin

Revenue
$7.7M
Net Income
-$667.7k
Profit Margin
-11.1%
DYNT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
DYNT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$27.8M
Liabilities
$12.9M
Debt to equity
0.87
DYNT's short-term assets ($12.01M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DYNT's short-term assets ($12.01M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DYNT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DYNT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$331.6k
Investing
-$10.6k
Financing
$382.6k
DYNT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

DYNT vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
DYNT$2.18M+5.13%-0.34x0.15x
NAOV$2.16M+4.16%-0.46x0.62x
TIVC$2.50M-1.22%-0.04x1.16x
BBLG$1.65M-0.66%-0.09x0.45x
TNON$2.77M-0.67%-0.11x0.76x

Dynatronics Stock FAQ

What is Dynatronics's quote symbol?

(NASDAQ: DYNT) Dynatronics trades on the NASDAQ under the ticker symbol DYNT. Dynatronics stock quotes can also be displayed as NASDAQ: DYNT.

If you're new to stock investing, here's how to buy Dynatronics stock.

What is the 52 week high and low for Dynatronics (NASDAQ: DYNT)?

(NASDAQ: DYNT) Dynatronics's 52-week high was $0.91, and its 52-week low was $0.37. It is currently -54.95% from its 52-week high and 10.81% from its 52-week low.

How much is Dynatronics stock worth today?

(NASDAQ: DYNT) Dynatronics currently has 5,308,519 outstanding shares. With Dynatronics stock trading at $0.41 per share, the total value of Dynatronics stock (market capitalization) is $2.18M.

Dynatronics stock was originally listed at a price of $25.00 in Dec 31, 1997. If you had invested in Dynatronics stock at $25.00, your return over the last 26 years would have been -98.36%, for an annualized return of -14.62% (not including any dividends or dividend reinvestments).

How much is Dynatronics's stock price per share?

(NASDAQ: DYNT) Dynatronics stock price per share is $0.41 today (as of May 24, 2024).

What is Dynatronics's Market Cap?

(NASDAQ: DYNT) Dynatronics's market cap is $2.18M, as of May 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Dynatronics's market cap is calculated by multiplying DYNT's current stock price of $0.41 by DYNT's total outstanding shares of 5,308,519.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.